Medindia
Medindia LOGIN REGISTER
Advertisement

Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12

Tuesday, September 11, 2007 General News
Advertisement
CHESTER, N.J., Sept. 11 Adams RespiratoryTherapeutics, Inc. (Nasdaq: ARxT) announced that it will commemorate the 10thanniversary of its incorporation with a celebration for employees onWednesday, Sept. 12, at Municipal Field (Gazebo Park) in Chester, New Jersey.Federal, state and local officials are scheduled to attend and participate ina ceremony recognizing Adams for its decade of success as a specialtypharmaceutical company focused on the treatment of respiratory disorders.
Advertisement

Adams, best known for its Mucinex(R) and Delsym(R) cough and cold productsand the nationwide Mr. Mucus(TM) consumer advertising campaign, commencedoperations in Fort Worth, Texas in September 1997. In April 2004, the Companyrelocated its corporate headquarters from Fort Worth to Chester, New Jersey.Adams currently employees nearly 500 people and its Chester facility housesmore than 80 of its employees. The Company has expanded its headquarteroperations twice since relocating to Chester in 2004 and doubled its portfolioof marketed respiratory products this year.
Advertisement

"On the occasion of this important milestone, I applaud our employees,whose talents and tireless efforts have fueled Adams' phenomenal growth in thepast several years," said Michael J. Valentino, president & CEO. "I'm proudof our accomplishments and I look forward to a second decade of success withmultiple new product introductions and our planned expansion into theprescription respiratory market."

"I congratulate Adams Respiratory Therapeutics on its 10-year anniversary,and the tremendous growth and success that this company has achieved in such ashort period of time," said Stanley Kosierowski, COO and SVP business support,New Jersey Economic Development Authority, who is scheduled to attend thecelebration on September 12. "It is New Jersey's good fortune to havecompanies like Adams come to our state, where they create jobs, become goodneighbors and corporate citizens, and continue New Jersey's fine tradition ofimproving public health by providing important medicines for the entirenation."

In August 2007, Adams was named to Deloitte & Touche's prestigiousTechnology Fast 50 Program for New Jersey, a ranking of the 50 fastest growingtechnology, media, telecommunications, and life sciences companies in thearea. Adams was ranked No. 7 overall, based on achieving a revenue growthrate of 1,638 percent from 2002 to 2006.

About Adams Respiratory Therapeutics, Inc.

Adams is a specialty pharmaceutical company focused on the late-stagedevelopment, commercialization and marketing of over-the-counter andprescription pharmaceuticals for the treatment of respiratory disorders.

For additional information about Adams, please visit the web site atwww.adamsrt.com.

SOURCE Adams Respiratory Therapeutics, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close